SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Verrica Pharmaceuticals Q3 Results Preview: Revenue Estimated at 6.20 Million

Verrica Pharmaceuticals is scheduled to report Q3'26 results on November 09. Revenue is estimated at 6.20 million USD, with EPS anticipated at (0.50) USD; the release time is not specified.

VRCA
SquawkNews Desk

Related stories

Oracle Details $20 Billion Plan to Fund AI Buildout Oracle disclosed details of its previously announced plan to raise $20 billion to fund AI infrastructure expansion. Its stock fell Monday. M impact | EQUITY | Nov 02, 2026, 03:50 PM UTC Engineers India Shares Jump 15% to Two-Week High After Q2 Results Engineers India shares closed Monday up 15% at Rs.290, a two-week high, after upbeat September-quarter results. The stock has gained 44% in 2026. M impact | EQUITY | Nov 02, 2026, 03:48 PM UTC World Stocks Rebound as Oil Falls and Strong Data Is Published Global equities rebounded as oil prices declined and strong economic data was published. M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC Carnelian, HDFC AMC and L&T Acquire 2.9% Stake in EAAA India Alternatives The investors collectively acquired the stake through open-market transactions on EAAA India Alternatives’ first day of trading, November 2. M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC Global stocks rise as oil falls and data prove positive M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC Global Stocks Rise as Oil Pullback and Solid Data Lift Sentiment Global stocks were headed higher after oil prices fell sharply, reversing some of the gloom from Friday’s US tech rout. The Nasdaq was up 1.2% and the S&P 500 rose 1% at the open. M impact | EQUITY | Nov 02, 2026, 03:46 PM UTC